Report says newer generics, AWPs are inflating drug costs.Judging by the tone of a recent hearing, U.S. representatives are set to take a hard look at how the government decides on Medicaid drug payments.During "Medicaid Prescription Drugs: Examining Options for Payment Reform," held in Washington in late June, several reps decried the paradox plaguing the Medicaid drug payment system, which is supposed to be a tool for keeping prescription prices down. Despite the system's ostensible intentions, however, representatives claimed that it is serving a polar opposite purpose."Generic drugs are supposed to promote competition and...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: